Related Experiment Video
Updated: Jan 30, 2026

Mechanism of Kemeng Fang's Inhibition of Podocyte Apoptosis in Rats with Membranous Nephropathy through the PI3K/AKT Signaling Pathway
Published on: August 23, 2024
V-domain immunoglobulin suppressor of T-cell activation regulates CD4+ T cell activation and podocyte function
Zhijie Luo1, Qiqi Zhang1, Tingting Zhang1
1New Drug Screening and Pharmacodynamics Evaluation Center, State Key Laboratory of Natural Medicines, China Pharmaceutical University, Nanjing 210009, China.
The activation of V-domain immunoglobulin suppressor of T-cell activation (VISTA) has shown its therapeutic potential in murine lupus-like disease through immunoregulation, particularly suppressing CD4+ T cell activation. Podocytes are critical for preventing proteinuria in lupus nephritis (LN). However, the mechanisms by which VISTA regulate CD4+ T cells and renal podocytes remain unclear. Here, we demonstrated that CD4+ T cells from VISTA knockout mice showed upregulated phosphorylation of PI3K/AKT, increased secretion of IFN-γ, IL-17 and CD40L. Soluble VISTA mitigated inflammation and recovered the expression of structural proteins Podocin through inhibition of PI3K/AKT/mTOR signaling pathway and induction of autophagy. Moreover, previously demonstrated VISTA agonist Baloxavir marboxil decreased renal CD4+ T cells, restored the expression of Nephrin and Podocin, and promoted autophagy. Our study suggests that VISTA plays an important role in the pathogenesis of LN, which offers novel mechanisms and potential target for its application in LN therapy.
The activation of V-domain immunoglobulin suppressor of T-cell activation (VISTA) has shown its therapeutic potential in murine lupus-like disease through immunoregulation, particularly suppressing CD4+ T cell activation. Podocytes are critical for preventing proteinuria in lupus nephritis (LN). However, the mechanisms by which VISTA regulate CD4+ T cells and renal podocytes remain unclear. Here, we demonstrated that CD4+ T cells from VISTA knockout mice showed upregulated phosphorylation of PI3K/AKT, increased secretion of IFN-γ, IL-17 and CD40L. Soluble VISTA mitigated inflammation and recovered the expression of structural proteins Podocin through inhibition of PI3K/AKT/mTOR signaling pathway and induction of autophagy. Moreover, previously demonstrated VISTA agonist Baloxavir marboxil decreased renal CD4+ T cells, restored the expression of Nephrin and Podocin, and promoted autophagy. Our study suggests that VISTA plays an important role in the pathogenesis of LN, which offers novel mechanisms and potential target for its application in LN therapy.
Related Concept Videos
PI3K/mTOR/AKT Signaling Pathway
What is Cell Signaling?
Eukaryotic Transcription Activators
The binding domains are capable of recognizing and interacting with regulatory sequences on the DNA. These...
B Cell Activation and Differentiation
When naive B cells encounter a specific antigen that can bind to the B cell receptor (BCR) on their surface, they undergo sensitization to respond to the antigen's presence. Sensitization begins with...
Co-activators and Co-repressors
Cell-surface Signaling

